ENDRA Life Sciences Inc.
NASDAQ: NDRA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Alexander Y. Tokman
- Employees
- 21
- Headquarters
- Ann Arbor, United States
- IPO year
- 2017
- Market cap
- $4.7M
- Website
- https://www.endrainc.com
Loading NDRA…
Loading profile data…Frequently asked questions about NDRA
What does ENDRA Life Sciences Inc. (NDRA) do?
ENDRA Life Sciences Inc. specializes in advancing the capabilities of clinical diagnostic ultrasound. The company's primary development is thermo-acoustic enhanced ultrasound technology, which operates by emitting sound waves that echo off internal body components such as tissues, organs, and blood. This innovation is utilized in managing nonalc...
Where does NDRA trade?
ENDRA Life Sciences Inc. (NDRA) trades on the NASDAQ Capital Market.
What sector is NDRA in?
ENDRA Life Sciences Inc. (NDRA) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of ENDRA Life Sciences Inc.?
Alexander Y. Tokman is the chief executive officer of ENDRA Life Sciences Inc. (NDRA).
Where is ENDRA Life Sciences Inc. headquartered?
ENDRA Life Sciences Inc. is headquartered in United States.
Does NDRA pay a dividend?
ENDRA Life Sciences Inc. (NDRA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did NDRA go public?
ENDRA Life Sciences Inc. (NDRA) completed its initial public offering in 2017.